YD Bio Limited (NASDAQ:YDES – Get Free Report)’s stock price was up 9.8% during trading on Friday . The stock traded as high as $2.44 and last traded at $2.24. 83,139 shares were traded during mid-day trading, a decline of 74% from the average daily volume of 322,873 shares. The stock had previously closed at $2.04.
YD Bio Stock Up 9.8%
The business has a fifty day moving average of $2.89 and a 200 day moving average of $6.43.
Hedge Funds Weigh In On YD Bio
A hedge fund recently raised its position in YD Bio stock. Geode Capital Management LLC lifted its stake in shares of YD Bio Limited (NASDAQ:YDES – Free Report) by 10.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the quarter. Geode Capital Management LLC owned approximately 0.08% of YD Bio worth $711,000 as of its most recent filing with the Securities and Exchange Commission.
YD Bio Company Profile
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
See Also
- Five stocks we like better than YD Bio
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
